Treating HIV/AIDS is a lifelong commitment that demands strict adherence to drug protocols, consistent care, and a trusting relationship with health care providers.

For many people with HIV, finding the right doctor is the most important decision they'll make.

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.

Over the years, HIV/AIDS activists and their allies have been pioneers in creating new frontiers in the medical establishment. Through their efforts, the FDA drug approval procedures were reformed so promising new therapies could reach desperate patients quicker.

Those of us who lived through the worst of the HIV/AIDS epidemic from the early 1980s through the mid-1990s have a very special spot in our heart for home-based health care.

Sick people, particularly those with serious conditions, greatly prefer the company of their friends and family to residence in a hospital or nursing home.

Treating HIV/AIDS is a lifelong commitment that demands strict adherence to drug protocols, consistent care, and a trusting relationship with health care providers.